KAYLA MOURY: Open Payments
NPI 1922463256 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,843 in 95 payments from 28 companies in 2025. Trend: 2023 $1,850 · 2024 $2,167 · 2025 $2,843
Food & beverage: $1,496Long term medical supply or device loan: $1,147Education: $200
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $1,306 |
| ABBVIE INC. | 7 | $181 |
| PFIZER INC. | 9 | $137 |
| Daiichi Sankyo Inc. | 6 | $136 |
| SEAGEN INC. | 1 | $100 |
| Merck Sharp & Dohme LLC | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| Eisai Inc. | 5 | $85 |
| Janssen Biotech, Inc. | 3 | $68 |
| Celgene Corporation | 3 | $67 |
Products named: KISQALI, VENCLEXTA, Enhertu, KEYTRUDA, Lenvima, OPDUALAG, Trodelvy, DATROWAY.
Industry payments across AR — which companies pay providers there.
